PREVAIL Begins Vaccinations in the Phase 2a Lassa Fever Vaccine Study
MONROVIA – On May 13, 2024, participants in Monrovia, Liberia, were vaccinated with a Lassa fever vaccine candidate as part ...
MONROVIA – On May 13, 2024, participants in Monrovia, Liberia, were vaccinated with a Lassa fever vaccine candidate as part ...
